Krystal Biotech (KRYS) IPO Opens Modestly Higher

Today's IPO for Krystal Biotech (NASDAQ: KRYS) opened for trading at $10.50 after pricing 3,960,000 shares of common stock at a price to the public of $10.00 per share.

In addition, Krystal has granted the underwriters a 30-day option to purchase up to an additional 594,000 shares of common stock to cover over-allotments, if any.

Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc., is acting as sole book-running manager in connection with the offering.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases

You May Also Be Interested In

• Market Technology Acquisition Corp closes $205M IPO on Nasdaq
• Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026
• Southern Cross Acquisition closes $115M IPO on Nasdaq